Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Katsumichi Iki is active.

Publication


Featured researches published by Katsumichi Iki.


Surgery Today | 2006

Lower esophageal sphincter- and vagus-preserving proximal partial gastrectomy for early cancer of the gastric cardia.

Toshihiro Hirai; Hideo Matsumoto; Katsumichi Iki; Yoko Hirabayashi; Yukiko Kawabe; Masaharu Ikeda; Masahiro Yamamura; Shinji Hato; Atsushi Urakami; Kazuki Yamashita; Tsukasa Tsunoda; Ken Haruma

PurposeProximal gastrectomy and lymph node dissection are often performed for T1 cancer of the gastric cardia; however, direct esophagogastrostomy is frequently complicated by reflux esophagitis. We describe a simple technique for preventing esophageal reflux and discuss its results.MethodsThis technique is indicated for T1 cancer of the gastric cardia without lymphadenopathy. Partial resection, including the lesion, is performed, preserving the vagus nerve and lower esophageal sphincter (LES). Lymph node dissection is done around the left gastric, celiac, and splenic arteries. The esophagus is then anastomosed to the anterior wall in the center of the remnant stomach.ResultsWe evaluated the results of this procedure in eight patients. X-ray films showed no esophageal reflux in either the supine or the right decubitus position. None of the patients complained of reflux or other dyscrasic symptoms, and none had any feeling of microgastria. One patient had some localized erosion near the anastomosis.ConclusionsThis simple and safe technique does not result in post-gastrectomy syndrome or microgastria, and the risk of leaving cancer cells is minimal.


Digestive Surgery | 2003

Giant splenic artery aneurysm associated with chronic pancreatitis.

Katsumichi Iki; Tsukasa Tsunoda

Accessible online at: www.karger.com/dsu Although splenic artery aneurysms (SAAs) are the most frequently occurring aneurysms of the visceral arteries, giant aneurysms of more than 3.0 cm are uncommon. Herein is reported the case of a 47-year-old man with a history of chronic alcoholic pancreatitis who was admitted complaining of sudden severe pain in the left upper abdomen. Ultrasonography of the upper abdomen revealed an 11-cm hypoechoic mass in close relation to the splenic artery. With pulsed and color Doppler imaging, blood was seen to flow into the mass during systole and


International Journal of Clinical Oncology | 2005

In vitro detection of cross-resistant and non-cross-resistant agents with fluorouracil for patients with colorectal cancer.

Kazuki Yamashita; Atsushi Urakami; Tadahiko Kubozoe; Masaharu Ikeda; Yoko Hirabayashi; Masahiro Yamamura; Katsumichi Iki; Takashi Akiyama; Hideo Matsumoto; Toshihiro Hirai; Yoshito Sadahira; Tsukasa Tsunoda

BackgroundFluorouracil-based chemotherapy, such as that with 5-fluorouracil (5-FU)/leucovorin, is standard as first-line chemotherapy for advanced colorectal cancer (CRC) in Japan. However, the best agent for second-line chemotherapy after fluorouracil failure is yet to be determined. This study was undertaken to find an appropriate agent for second-line chemotherapy.MethodsSeventy-five tumor specimens from CRC patients with no prior chemotherapy were obtained operatively and their chemosensitivity to five anticancer agents; i.e., 5-FU, mitomycin C (MMC), cisplatin, docetaxel, and an active metabolite of irinotecan (SN-38), was analyzed in an in vitro chemosensitivity test. In this method, the degree of chemosensitivity was expressed as the percent T/C ratio, where T was the total volume of the tumor colonies in the treated group and C was that of the control group. Pearsons correlation coefficients were used to assess the relationship between two agents.ResultsFifty-eight specimens (colon, 28; rectum, 30) were successfully analyzed. Positive correlations with 5-FU chemosensitivity were verified for the chemosensitivity of MMC, cisplatin, and docetaxel. No correlation with 5-FU chemosensitivity was verified for SN-38 chemosensitivity. Although the functional mechanism of each of the agents differs from that of 5-FU, with the exception of irinotecan, they all had a spectrum closely similar to the 5-FU spectrum.ConclusionOnly irinotecan exhibited a spectrum independent of that of 5-FU, thus indicating that it could be an appropriate agent for second-line chemotherapy after fluorouracil failure.


Journal of Gastroenterology | 2001

Primary adenocarcinoma of the duodenum demonstrated by ultrasonography.

Katsumichi Iki; Atsushi Nogami; Hideki Harada; Muneo Echigo; Takashi Kiyama; Tsukasa Tsunoda; Toshifumi Eto

Abstract: A 57 year-old man presented with abdominal discomfort and melena. Abdominal ultrasonography clearly revealed a duodenal tumor as a hypoechoic mass in the transverse segment of the duodenum. The lesion was a 4 × 4-cm oval mass with partial concavity, an irregular surface, high-level central echoes, and a hypoechoic periphery. After confirmation of the diagnosis of duodenal carcinoma, a pylorus-preserving pancreatoduodenectomy was performed curatively. Pathological examination revealed moderately differentiated tubular adenocarcinoma partially invading the pancreatic parenchyma. Ultrasonography can be used to detect lesions of the transverse segment of the duodenum as the first imaging procedure.


Carcinogenesis | 1999

Overexpression of midkine in lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine in rats and its increase with progression

Hiroyuki Sakitani; Masahiro Tsutsumi; Kenji Kadomatsu; Shinya Ikematsu; Makoto Takahama; Katsumichi Iki; Toshifumi Tsujiuchi; Takashi Muramatsu; Sdatoshi Sakuma; Toshisuke Sakaki; Yoichi Konishi


Journal of Hepato-biliary-pancreatic Surgery | 1998

Staging and treatment for patients with pancreatic cancer : How small is an early pancreatic cancer?

Tsukasa Tsunoda; Yasuhisa Yamamoto; Masatoshi Kimoto; Hiroyuki Imai; Sueharu Iwamoto; Seiji Kawasaki; Kunihiro Kawashima; Yoshiyuki Tadaoka; Toshimitsu Majima; Eishi Onuma; Katsumichi Iki; Tadahiko Kubozoe; Toshifumi Eto


Carcinogenesis | 1999

Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine

Katsumichi Iki; Masahiro Tsutsumi; Akira Kido; Hiroyuki Sakitani; Makoto Takahama; Masatoshi Yoshimoto; Masaaki Motoyama; Kunihiko Tatsumi; Tsukasa Tsunoda; Yoichi Konishi


Annals of Thoracic and Cardiovascular Surgery | 2005

Surgical Oncotaxis : Excessive Surgical Stress and Postoperative Complications Contribute to Enhancing Tumor Metastasis, Resulting in a Poor Prognosis for Cancer Patients

Toshihiro Hirai; Hideo Matsumoto; Kazuki Yamashita; Atsushi Urakami; Katsumichi Iki; Masahiro Yamamura; Tsukasa Tsunoda


Surgery | 2001

Preoperative diagnosis of acute appendiceal diverticulitis by ultrasonography

Katsumichi Iki; Muneo Echigo; Atsushi Nogami; Sueharu Iwamoto; Tomoyuki Takeo; Tsukasa Tsunoda; Toshifumi Eto


Surgery | 2002

Hemorrhagic acalculous cholecystitis associated with hemodialysis.

Katsumichi Iki; Hiroshi Inada; Masataka Satoh; Tsukasa Tsunoda

Collaboration


Dive into the Katsumichi Iki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge